Sentence Index File 1,Sentence in File 1,Sentence Index File 2,Sentence in File 2,Similarity Score
0,Macrophage migration inhibitory factor is critical for dengue NS1-induced endothelial glycocalyx degradation and hyperpermeability,0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0.550595749083099
1,MIF in DENV NS1-induced endothelial glycocalyx degradation and hyperpermeability,47,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice.,0.5433068643874144
2,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
3,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
4,"However, it is unclear whether MIF is directly involved in NS1-induced glycocalyx degradation.",108,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",0.35825454969284276
5,"In this study, we observed that among NS1, MIF and glycocalyx degradation-related molecules, the HPA-1, metalloproteinase 9 (MMP-9) and syndecan 1 (CD138) serum levels were all increased in dengue patients, and only NS1 and MIF showed a positive correlation with the CD138 level in severe patients.",79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,0.25138342279122466
6,"In this study, we observed that among NS1, MIF and glycocalyx degradation-related molecules, the HPA-1, metalloproteinase 9 (MMP-9) and syndecan 1 (CD138) serum levels were all increased in dengue patients, and only NS1 and MIF showed a positive correlation with the CD138 level in severe patients.",79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,0.25138342279122466
7,"To further characterize and clarify the relationship between MIF and CD138, we used recombinant NS1 to stimulate human cells in vitro and challenge mice in vivo.",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",0.2475433704427664
8,"Our tabulated results suggested that NS1 stimulation could induce human endothelial cells to secrete HPA-1 and immune cells to secrete MMP-9, resulting in endothelial glycocalyx degradation and hyperpermeability.",6,"Our tabulated results suggested that NS1 stimulation could induce human endothelial cells to secrete HPA-1 and immune cells to secrete MMP-9, resulting in endothelial glycocalyx degradation and hyperpermeability.",1.0000000000000002
9,"Our tabulated results suggested that NS1 stimulation could induce human endothelial cells to secrete HPA-1 and immune cells to secrete MMP-9, resulting in endothelial glycocalyx degradation and hyperpermeability.",6,"Our tabulated results suggested that NS1 stimulation could induce human endothelial cells to secrete HPA-1 and immune cells to secrete MMP-9, resulting in endothelial glycocalyx degradation and hyperpermeability.",1.0000000000000002
10,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
11,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
12,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
13,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
14,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
15,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",1.0000000000000002
16,"Taken together, these results suggest that MIF directly engages in dengue NS1-induced glycocalyx degradation and that targeting MIF may represent a possible therapeutic approach for preventing dengue-induced vascular leakage.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.2816611439910271
17,DENV NS1 induces endothelial glycocalyx degradation and hyperpermeability via HPA-1 and MMP-9 activation in an MIF-dependent manner.,94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.4089164413471654
18,DENV NS1 induces endothelial glycocalyx degradation and hyperpermeability via HPA-1 and MMP-9 activation in an MIF-dependent manner.,94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.4089164413471654
19,DENV NS1 induces endothelial glycocalyx degradation and hyperpermeability via HPA-1 and MMP-9 activation in an MIF-dependent manner.,94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.4089164413471654
20,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
21,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
22,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
23,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
24,"The increase in vascular permeability is the primary cause of plasma leakage, which finally causes hypotension and circulatory collapse.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.192726748621367
25,"The increase in vascular permeability is the primary cause of plasma leakage, which finally causes hypotension and circulatory collapse.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.192726748621367
26,"An increase in endothelial permeability is frequently associated with the degradation of the endothelial glycocalyx [2, 3].",82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.29464168182421996
27,"Under normal physiological conditions, the glycocalyx acts as a barrier that controls numerous physiological processes, especially preventing the adhesion of leucocytes and platelets to the vessel walls [4, 5].",46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,0.10854711679719854
28,"Under normal physiological conditions, the glycocalyx acts as a barrier that controls numerous physiological processes, especially preventing the adhesion of leucocytes and platelets to the vessel walls [4, 5].",46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,0.10854711679719854
29,"Shedding of the endothelial glycocalyx is related to the activation of a heparan sulfate-specific heparanase, HPA-1",7,"Activated HPA-1 enhances shedding of the transmembrane heparan sulfate proteoglycan syndecan-1 (CD138) and elevates the level of CD138 in the bloodstream [7, 9, 10].",0.323827245709467
30,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
31,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
32,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
33,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
34,Activated HPA-1 enhances shedding of the transmembrane heparan sulfate proteoglycan syndecan-1 (CD138) and elevates the level of CD138 in the bloodstream,7,"Activated HPA-1 enhances shedding of the transmembrane heparan sulfate proteoglycan syndecan-1 (CD138) and elevates the level of CD138 in the bloodstream [7, 9, 10].",0.9662760964498103
35,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
36,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
37,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
38,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
39,"In addition, matrix metalloproteinases (MMPs) are capable of digesting many types of extracellular matrix, including the endothelial glycocalyx",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.19745295644319208
40,"In addition, matrix metalloproteinases (MMPs) are capable of digesting many types of extracellular matrix, including the endothelial glycocalyx",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.19745295644319208
41,"Glycocalyx degradation is strongly associated with severe plasma leakage in dengue patients [13, 14].",82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.16533812938350673
42,"Recently, DENV nonstructural protein 1 (NS1) was found to play an important role in the pathogenesis of DENV-induced vascular leakage [15–17].",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.35161950371121176
43,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",1.0000000000000002
44,"In our previous study, we found that DENV NS1 can increase vascular permeability through macrophage migration inhibitory factor (MIF)-induced autophagy",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0.3227433897438188
45,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
46,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
47,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
48,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
49,"MIF is a chemokine-like inflammatory cytokine that binds to cell surface receptors (CD74 and/or CXCR2/4/7) and activates downstream signals, such as MAPK/ERK, to modulate inflammatory and immune responses [20–25].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.11265526556475297
50,"MIF is a chemokine-like inflammatory cytokine that binds to cell surface receptors (CD74 and/or CXCR2/4/7) and activates downstream signals, such as MAPK/ERK, to modulate inflammatory and immune responses [20–25].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.11265526556475297
51,"MIF is a chemokine-like inflammatory cytokine that binds to cell surface receptors (CD74 and/or CXCR2/4/7) and activates downstream signals, such as MAPK/ERK, to modulate inflammatory and immune responses [20–25].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.11265526556475297
52,"MIF is a chemokine-like inflammatory cytokine that binds to cell surface receptors (CD74 and/or CXCR2/4/7) and activates downstream signals, such as MAPK/ERK, to modulate inflammatory and immune responses [20–25].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.11265526556475297
53,"MIF is a chemokine-like inflammatory cytokine that binds to cell surface receptors (CD74 and/or CXCR2/4/7) and activates downstream signals, such as MAPK/ERK, to modulate inflammatory and immune responses [20–25].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.11265526556475297
54,"DENV infection can induce MIF secretion [26, 27], and the concentration of MIF is positively correlated with dengue severity [28].",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.1744794748025917
55,"Furthermore, DENV infection-induced disease was found to be less severe in MIF knockout (Mif-/-) mice than in normal mice [29].",10,"Furthermore, DENV infection-induced disease was found to be less severe in MIF knockout (Mif  ) mice than in normal mice [29].",1.0
56,"However, it is unclear whether MIF is directly involved in NS1-induced glycocalyx degradation.",108,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",0.35825454969284276
57,"To address this question, we studied the effects of NS1 on the secretion of MIF, HPA-1, MMP-9, and CD138 both in vitro and in vivo.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.32044378248697547
58,"To address this question, we studied the effects of NS1 on the secretion of MIF, HPA-1, MMP-9, and CD138 both in vitro and in vivo.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.32044378248697547
59,"To address this question, we studied the effects of NS1 on the secretion of MIF, HPA-1, MMP-9, and CD138 both in vitro and in vivo.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.32044378248697547
60,"To address this question, we studied the effects of NS1 on the secretion of MIF, HPA-1, MMP-9, and CD138 both in vitro and in vivo.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.32044378248697547
61,"Most importantly, the NS1-induced increases in HPA-1, MMP-9, and CD138 were all inhibited in the presence of MIF inhibitors or antibodies both in vitro and in vivo, indicating that NS1-induced MIF secretion may play an important role in the pathogenesis of DENV NS1-induced glycocalyx degradation and vascular leakage.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.4510587163203927
62,"Most importantly, the NS1-induced increases in HPA-1, MMP-9, and CD138 were all inhibited in the presence of MIF inhibitors or antibodies both in vitro and in vivo, indicating that NS1-induced MIF secretion may play an important role in the pathogenesis of DENV NS1-induced glycocalyx degradation and vascular leakage.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.4510587163203927
63,"Most importantly, the NS1-induced increases in HPA-1, MMP-9, and CD138 were all inhibited in the presence of MIF inhibitors or antibodies both in vitro and in vivo, indicating that NS1-induced MIF secretion may play an important role in the pathogenesis of DENV NS1-induced glycocalyx degradation and vascular leakage.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.4510587163203927
64,"Most importantly, the NS1-induced increases in HPA-1, MMP-9, and CD138 were all inhibited in the presence of MIF inhibitors or antibodies both in vitro and in vivo, indicating that NS1-induced MIF secretion may play an important role in the pathogenesis of DENV NS1-induced glycocalyx degradation and vascular leakage.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.4510587163203927
65,"Most importantly, the NS1-induced increases in HPA-1, MMP-9, and CD138 were all inhibited in the presence of MIF inhibitors or antibodies both in vitro and in vivo, indicating that NS1-induced MIF secretion may play an important role in the pathogenesis of DENV NS1-induced glycocalyx degradation and vascular leakage.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.4510587163203927
66,"Comparison of NS1, HPA-1, MMP-9, CD138 and MIF serum concentrations in dengue patients",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.25613661361046963
67,"Comparison of NS1, HPA-1, MMP-9, CD138 and MIF serum concentrations in dengue patients",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.25613661361046963
68,"Comparison of NS1, HPA-1, MMP-9, CD138 and MIF serum concentrations in dengue patients",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.25613661361046963
69,"Comparison of NS1, HPA-1, MMP-9, CD138 and MIF serum concentrations in dengue patients",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.25613661361046963
70,The concentrations of NS1 and HPA-1 were increased in both dengue patients with warning signs and severe dengue patients (Fig 1A and 1B).,56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.17729183485750513
71,The concentrations of MMP-9 were also significantly elevated in dengue patients with warning signs but not in severe dengue patients (Fig 1C).,100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.23402902485859786
72,The concentrations of CD138 and MIF were significantly elevated in the serum of severe dengue patients compared to dengue patients with warning signs (Fig 1D and 1E).,100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.2020935409061773
73,The concentrations of CD138 and MIF were significantly elevated in the serum of severe dengue patients compared to dengue patients with warning signs (Fig 1D and 1E).,100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.2020935409061773
74,"To further elucidate the correlation between CD138 and the other molecules, the serum concentrations of NS1, MIF, HPA-1 and MMP-9 in severe dengue patients were plotted against the concentration of CD138 (Fig 2).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.2330319325064323
75,"To further elucidate the correlation between CD138 and the other molecules, the serum concentrations of NS1, MIF, HPA-1 and MMP-9 in severe dengue patients were plotted against the concentration of CD138 (Fig 2).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.2330319325064323
76,"To further elucidate the correlation between CD138 and the other molecules, the serum concentrations of NS1, MIF, HPA-1 and MMP-9 in severe dengue patients were plotted against the concentration of CD138 (Fig 2).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.2330319325064323
77,"To further elucidate the correlation between CD138 and the other molecules, the serum concentrations of NS1, MIF, HPA-1 and MMP-9 in severe dengue patients were plotted against the concentration of CD138 (Fig 2).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.2330319325064323
78,Only NS1 and MIF showed a positive correlation with CD138 in the sera of severe dengue patients (Fig 2A and 2B).,56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.18116533612755936
79,Only NS1 and MIF showed a positive correlation with CD138 in the sera of severe dengue patients (Fig 2A and 2B).,56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.18116533612755936
80,These results suggest that NS1 and MIF may play important roles in CD138 shedding in severe dengue patients.,55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.5581316665608095
81,"The correlations of the concentrations of (A) NS1, (B) MIF, (C) HPA-1 and (D) MMP-9 and CD138 in the same group of severe dengue patients were plotted.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.23070735591915367
82,"The correlations of the concentrations of (A) NS1, (B) MIF, (C) HPA-1 and (D) MMP-9 and CD138 in the same group of severe dengue patients were plotted.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.23070735591915367
83,"The correlations of the concentrations of (A) NS1, (B) MIF, (C) HPA-1 and (D) MMP-9 and CD138 in the same group of severe dengue patients were plotted.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.23070735591915367
84,"The correlations of the concentrations of (A) NS1, (B) MIF, (C) HPA-1 and (D) MMP-9 and CD138 in the same group of severe dengue patients were plotted.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.23070735591915367
85,DENV NS1-induced endothelial HPA-1 secretion leads to glycocalyx degradation and hyperpermeability and is MIF dependent,103,"Next, we showed that the DENV NS1 stimulation of endothelial cells and leukocytes could induce HPA-1 and MMP-9 secretion, respectively, causing endothelial glycocalyx degradation and hyperpermeability.",0.30791798499821904
86,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
87,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
88,The results show that CD138 was significantly increased in cell culture medium after 24 h of NS1 treatment (Fig 3A).,79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,0.29394072046375075
89,"To confirm that this effect was induced by NS1, anti-NS1 monoclonal antibody (mAb) was used to block the effect of NS1.",13,"To confirm that this effect was induced by NS1, anti-NS1 monoclonal antibody (mAb) was used to block the effect of NS1.",1.0000000000000002
90,"Anti-NS1 mAb 2E8, which can inhibit NS1-induced vascular leakage, was able to inhibit NS1-induced CD138 shedding (Fig 3B)",15,"Anti-NS1 mAb 2E8, which can inhibit NS1-induced vascular leakage, was able to inhibit NS1-induced CD138 shedding (Fig 3B) [19].",0.9614642747413623
91,"Anti-NS1 mAb 2E8, which can inhibit NS1-induced vascular leakage, was able to inhibit NS1-induced CD138 shedding (Fig 3B)",15,"Anti-NS1 mAb 2E8, which can inhibit NS1-induced vascular leakage, was able to inhibit NS1-induced CD138 shedding (Fig 3B) [19].",0.9614642747413623
92,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
93,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
94,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
95,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
96,"In contrast, another anti-NS1 mAb (DN5C6), which was used as a negative control, failed to inhibit NS1-induced CD138 shedding from endothelial cells (Fig 3B)",16,"In contrast, another anti-NS1 mAb (DN5C6), which was used as a negative control, failed to inhibit NS1-induced CD138 shedding from endothelial cells (Fig 3B) [19].",0.9672986606709182
97,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
98,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
99,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
100,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
101,"NS1 stimulation also increased the active HPA-1 level in endothelial cell lysates, which was abolished by mAb 2E8 but not control mouse IgG (S2A Fig).",74,"NS1 stimulation also increased the active HPA-1 level in endothelial cell lysates, which was abolished by mAb 2E8 but not control mouse IgG (S2A Fig).",1.0
102,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",1.0000000000000002
103,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",1.0000000000000002
104,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",1.0000000000000002
105,Inoculating the mice with native but not heat-denatured recombinant HPA-1 directly induced vascular leakage (S2B Fig).,50,"Furthermore, the inhibition of MIF and MMP-9 also attenuated NS1-induced vascular leakage in mice (S9 Fig).",0.21662185495484565
106,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",75,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",1.0
107,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",75,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",1.0
108,DENV NS1-induced HPA-1 secretion leading to glycocalyx degradation and hyperpermeability is MIF dependent.,68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.40800387797260307
109,DENV NS1-induced HPA-1 secretion leading to glycocalyx degradation and hyperpermeability is MIF dependent.,68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.40800387797260307
110,DENV NS1-induced HPA-1 secretion leading to glycocalyx degradation and hyperpermeability is MIF dependent.,68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.40800387797260307
111,DENV NS1-induced HPA-1 secretion leading to glycocalyx degradation and hyperpermeability is MIF dependent.,68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.40800387797260307
112,"(A) HUVECs were treated with PBS or 20 μg/ml NS1 recombinant proteins for the indicated time, followed by collection of the supernatants for CD138 detection by ELISA.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.17045823913952973
113,"(n = 4) (B) HUVECs were treated with PBS, 20 μg/ml NS1, or 20 μg/ml NS1 mixed with 10 μg/ml anti-NS1 antibodies (2E8 or DN5C6).",77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.3269965632014572
114,"(n = 4) (B) HUVECs were treated with PBS, 20 μg/ml NS1, or 20 μg/ml NS1 mixed with 10 μg/ml anti-NS1 antibodies (2E8 or DN5C6).",77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.3269965632014572
115,"(C) HUVECs seeded as monolayers in upper Transwell chambers were treated with PBS, 20 μg/ml NS1 or 20 μg/ml NS1 mixed with DMSO or the indicated concentration of OGT 2115.",77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.17613083274171432
116,"(C) HUVECs seeded as monolayers in upper Transwell chambers were treated with PBS, 20 μg/ml NS1 or 20 μg/ml NS1 mixed with DMSO or the indicated concentration of OGT 2115.",77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.17613083274171432
117,(D) HUVECs were treated with PBS or 20 μg/ml NS1 with or without 5 μM OGT 2115.,75,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",0.15792029216518408
118,(D) HUVECs were treated with PBS or 20 μg/ml NS1 with or without 5 μM OGT 2115.,75,"Furthermore, cotreatment with OGT 2115 attenuated NS1-induced endothelial hyperpermeability (Fig 3C) and reduced CD138 release to levels similar to those of the phosphate-buffered saline (PBS) control in vitro (Fig 3D).",0.15792029216518408
119,"(E) HUVECs were treated with PBS or 20 μg/ml NS1 with or without 100 μM p425, 50 μM ISO-1, or 10 μg/ml anti-MIF antibodies, as indicated.",77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.23810195421567473
120,"HUVECs were treated with PBS or 20 μg/ml NS1 with or without p425, ISO-1 or anti-MIF antibodies.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.16504478271081283
121,"HUVECs were treated with PBS or 20 μg/ml NS1 with or without p425, ISO-1 or anti-MIF antibodies.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.16504478271081283
122,"HUVECs were treated with PBS or 20 μg/ml NS1 with or without p425, ISO-1 or anti-MIF antibodies.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.16504478271081283
123,"HUVECs were treated with PBS or 20 μg/ml NS1 with or without p425, ISO-1 or anti-MIF antibodies.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.16504478271081283
124,"HUVECs were treated with PBS or 20 μg/ml NS1 with or without p425, ISO-1 or anti-MIF antibodies.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.16504478271081283
125,(G) HUVECs were treated with PBS or NS1 (20 μg/ml) with or without anti-MIF polyclonal antibodies (10 μg/ml) for 24 h. The distribution of HPA-1 (red) and CD138 (green) was assessed by staining with specific antibodies.,77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,0.2488794659705993
126,Sialic acid expression on HUVECs monolayers was assessed by staining with WGA-FITC (green).,69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.23026882975657573
127,"In addition to HPA-1, MIF is also capable of inducing endothelial hyperpermeability [19].",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.2758626733718642
128,"As a result, the MIF concentration in the conditioned medium obtained from NS1-stimulated HUVECs was measured.",43,Similar results were found for the supernatant obtained from NS1-stimulated leukocytes (S6 Fig).,0.29156258226123016
129,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,77,The result shows that 10 μg/ml NS1 was sufficient to induce MIF secretion (S3A Fig).,1.0
130,"Furthermore, the conditioned medium obtained from NS1-stimulated HUVECs could induce endothelial hyperpermeability and CD138 shedding after incubation with another HUVEC monolayer (S3B and S3C Fig).",21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,0.30734442466745815
131,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",1.0
132,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",1.0
133,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",1.0
134,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",1.0
135,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",1.0
136,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,1.0000000000000004
137,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,1.0000000000000004
138,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,1.0000000000000004
139,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,1.0000000000000004
140,"Interestingly, the NS1-blocking antibody 2E8 only partially diminished the conditioned medium-induced HUVEC hyperpermeability but not the conditioned medium-induced HUVEC CD138 shedding (S3D and S3E Fig).",36,"Interestingly, the NS1-blocking antibody 2E8 only partially diminished the conditioned medium-induced HUVEC hyperpermeability but not the conditioned medium-induced HUVEC CD138 shedding (S3D and S3E Fig).",1.0
141,"Interestingly, the NS1-blocking antibody 2E8 only partially diminished the conditioned medium-induced HUVEC hyperpermeability but not the conditioned medium-induced HUVEC CD138 shedding (S3D and S3E Fig).",36,"Interestingly, the NS1-blocking antibody 2E8 only partially diminished the conditioned medium-induced HUVEC hyperpermeability but not the conditioned medium-induced HUVEC CD138 shedding (S3D and S3E Fig).",1.0
142,"Cotreatment with MIF inhibitors (anti-MIF antibodies, ISO-1, and p425) and NS1 also attenuated the NS1-induced HPA-1 secretion (Fig 3E) and CD138 shedding of endothelial cells (Fig 3F).",21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,0.3297409672065332
143,"Cotreatment with MIF inhibitors (anti-MIF antibodies, ISO-1, and p425) and NS1 also attenuated the NS1-induced HPA-1 secretion (Fig 3E) and CD138 shedding of endothelial cells (Fig 3F).",21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,0.3297409672065332
144,"In addition, we also visualized the HPA-1 expression, CD138 deposition and sialic acid expression using immunofluorescence with anti-HPA antibodies, anti-CD138 antibodies and wheat germ agglutinin (WGA) lectin which can bind to sialic acids and other sugars such as N-acetylglucosamine.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.35310761569314086
145,"In addition, we also visualized the HPA-1 expression, CD138 deposition and sialic acid expression using immunofluorescence with anti-HPA antibodies, anti-CD138 antibodies and wheat germ agglutinin (WGA) lectin which can bind to sialic acids and other sugars such as N-acetylglucosamine.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.35310761569314086
146,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
147,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
148,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
149,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
150,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
151,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.9999999999999999
152,"However, the HPA-1 inhibitor OGT 2115 failed to affect MIF secretion, suggested that MIF is the upstream effector of HPA-1 (S3F Fig).",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",0.3024508299002342
153,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,1.0000000000000002
154,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,1.0000000000000002
155,The increased HPA-1 expression and CD138 deposition after MIF stimulation could also be observed by immunofluorescence (S4C Fig).,69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.41086838206631887
156,The increased HPA-1 expression and CD138 deposition after MIF stimulation could also be observed by immunofluorescence (S4C Fig).,69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.41086838206631887
157,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",80,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",1.0000000000000002
158,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",80,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",1.0000000000000002
159,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes,81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,1.0
160,Since MMPs can degrade the endothelial glycocalyx and several MMPs are upregulated during DENV infection,42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.21976225037014474
161,Since MMPs can degrade the endothelial glycocalyx and several MMPs are upregulated during DENV infection,42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.21976225037014474
162,"[30, 31], we speculated that MMPs are involved in NS1-induced glycocalyx degradation.",58,It is known that DENV infection induces dendritic cells to secrete MMP-9 [31].,0.19588779871458478
163,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.9999999999999999
164,"However, we found that NS1 barely induced MMP-9 secretion in HUVECs (Fig 4A).",83,"However, we found that NS1 barely induced MMP-9 secretion in HUVECs (Fig 4A).",1.0
165,"Since MMPs are primarily secreted by leukocytes (white blood cells, WBCs), including neutrophils and monocytes [33], we tested whether NS1 could induce MMP secretion in human leukocytes, peripheral blood mononuclear cells (PBMCs), and THP-1 human monocytes.",39,"Since MMPs are primarily secreted by leukocytes (white blood cells, WBCs), including neutrophils and monocytes [33], we tested whether NS1 could induce MMP secretion in human leukocytes, peripheral blood mononuclear cells (PBMCs), and THP-1 human monocytes.",1.0000000000000002
166,"We found that NS1 induced MMP-9 secretion in freshly isolated leukocytes after 3 h of stimulation (Fig 4B), an effect that was attenuated by the NS1-blocking antibody 2E8 (Fig 4C).",40,"We found that NS1 induced MMP-9 secretion in freshly isolated leukocytes after 3 h of stimulation (Fig 4B), an effect that was attenuated by the NS1-blocking antibody 2E8 (Fig 4C).",1.0
167,"Similarly, NS1 induced phorbol myristate acetate (PMA)-activated THP-1 cells to secrete MMP-9 after incubation for 3 h (Fig 4D).",41,"Similarly, NS1 induced phorbol myristate acetate (PMA)-activated THP-1 cells to secrete MMP-9 after incubation for 3 h (Fig 4D).",1.0000000000000002
168,"However, neither MIF nor MMP-9 secretion was significantly induced in NS1-stimulated PBMCs compared to the controls (S5A and S5B Fig).",105,"In this study, we further demonstrated that the NS1 stimulation of leukocytes but not endothelial cells nor PBMCs could induce MMP-9 secretion.",0.24088975565216153
169,"However, neither MIF nor MMP-9 secretion was significantly induced in NS1-stimulated PBMCs compared to the controls (S5A and S5B Fig).",105,"In this study, we further demonstrated that the NS1 stimulation of leukocytes but not endothelial cells nor PBMCs could induce MMP-9 secretion.",0.24088975565216153
170,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",1.0000000000000002
171,"The results show that MMP-8, MMP-9, and TIMP-1 were increased in the culture medium of NS1-treated THP-1 cells and leukocytes (Fig 4E).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.3426760418007526
172,"The results show that MMP-8, MMP-9, and TIMP-1 were increased in the culture medium of NS1-treated THP-1 cells and leukocytes (Fig 4E).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.3426760418007526
173,"The results show that MMP-8, MMP-9, and TIMP-1 were increased in the culture medium of NS1-treated THP-1 cells and leukocytes (Fig 4E).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.3426760418007526
174,"To confirm the activity of MMP-9, cell culture medium from NS1-treated PMA-activated THP-1 cells and leukocytes were analyzed using a gelatin zymography assay, which showed that NS1 induced both THP-1 cells and leukocytes to secrete pro-MMP-9 and activated MMP-9 (Fig 4F).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.3340429368754011
175,"To confirm the activity of MMP-9, cell culture medium from NS1-treated PMA-activated THP-1 cells and leukocytes were analyzed using a gelatin zymography assay, which showed that NS1 induced both THP-1 cells and leukocytes to secrete pro-MMP-9 and activated MMP-9 (Fig 4F).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.3340429368754011
176,NS1 induces MMP-9 secretion from human leukocytes but not HUVECs.,81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.4682082080880531
177,"(A) HUVECs were treated with PBS or NS1 for the indicated times; then, the supernatants were collected for MMP-9 detection by ELISA.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.21426492651594958
178,"(B) Isolated human leukocytes (WBCs) and (D) PMA-activated THP-1 cells were treated with PBS or NS1, and the culture medium was collected at the indicated times.",42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.2105739079171741
179,"(B) Isolated human leukocytes (WBCs) and (D) PMA-activated THP-1 cells were treated with PBS or NS1, and the culture medium was collected at the indicated times.",42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.2105739079171741
180,"(C) Isolated WBCs were treated with PBS, NS1, or NS1 mixed with anti-NS1 antibodies for 24 h, and the concentration of MMP-9 in the culture medium was determined by ELISA.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.19155544510034317
181,"(E) After PMA activation, THP-1 and primary isolated WBCs were subjected to the desired treatment.",68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.16130596595712066
182,"(E) After PMA activation, THP-1 and primary isolated WBCs were subjected to the desired treatment.",68,"In addition, NS1 can induce the expression and activation of HPA-1, leading to endothelial glycocalyx degradation and hyperpermeability [18].",0.16130596595712066
183,An MMP antibody array that detects various MMPs and TIMPs was used to assess the major subclass of MMPs induced by NS1.,42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.404833498952055
184,"THP-1 cells or WBCs were stimulated with PBS or NS1; then, the culture supernatants were collected and analyzed for extracellular matrix proteins.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.17480089327313383
185,"THP-1 cells or WBCs were stimulated with PBS or NS1; then, the culture supernatants were collected and analyzed for extracellular matrix proteins.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.17480089327313383
186,"Membranes of the human MMP antibody array were probed with the supernatant collected from bovine serum albumin (BSA)-treated THP-1 cells, BSA-treated WBCs, 20 μg/ml NS1-treated THP-1 cells or NS1-treated WBCs.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.18521544421580266
187,"Membranes of the human MMP antibody array were probed with the supernatant collected from bovine serum albumin (BSA)-treated THP-1 cells, BSA-treated WBCs, 20 μg/ml NS1-treated THP-1 cells or NS1-treated WBCs.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.18521544421580266
188,"The quantification of MMPs array membranes was analyzed by ImageJ. PC, positive control; NC, negative control.",16,"In contrast, another anti-NS1 mAb (DN5C6), which was used as a negative control, failed to inhibit NS1-induced CD138 shedding from endothelial cells (Fig 3B) [19].",0.21224962597746275
189,The gel was stained with Coomassie blue to reveal the white bands corresponding to the proteolysis of gelatin by MMPs.,42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.1500068610312653
190,DENV NS1-induced MMP-9 secretion from THP-1 cells increases endothelial permeability and glycocalyx degradation,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.40088430036060785
191,"To test whether the NS1-induced MMP-9 secretion of THP-1 cells causes endothelial hyperpermeability, the supernatant from NS1-treated THP-1 cells was incubated with HUVECs, and both permeability and CD138 shedding were examined.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.4073200870469304
192,"To test whether the NS1-induced MMP-9 secretion of THP-1 cells causes endothelial hyperpermeability, the supernatant from NS1-treated THP-1 cells was incubated with HUVECs, and both permeability and CD138 shedding were examined.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.4073200870469304
193,"The results show that after 3 h of treatment, the supernatant from NS1-treated THP-1 cells increased endothelial permeability (Fig 5A).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3372534072835173
194,This phenomenon was attenuated in the presence of the MMP-2/MMP-9 inhibitor SB-3CT and the MMP-9-specific inhibitor MMP-9 inhibitor I (Fig 5B and 5C).,59,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",0.2440198480072257
195,This phenomenon was attenuated in the presence of the MMP-2/MMP-9 inhibitor SB-3CT and the MMP-9-specific inhibitor MMP-9 inhibitor I (Fig 5B and 5C).,59,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",0.2440198480072257
196,The supernatant from untreated or PBS-treated THP-1 cells did not alter endothelial permeability (Fig 5B and 5C).,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3060161470051052
197,"Similarly, the supernatant from NS1-treated THP-1 cells also induced CD138 shedding from HUVECs (Fig 5D), and this effect was diminished by SB-3CT and MMP-9 inhibitor I (Fig 5E and 5F).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3200264162017956
198,"Similarly, the supernatant from NS1-treated THP-1 cells also induced CD138 shedding from HUVECs (Fig 5D), and this effect was diminished by SB-3CT and MMP-9 inhibitor I (Fig 5E and 5F).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3200264162017956
199,"Similarly, the supernatant from NS1-treated THP-1 cells also induced CD138 shedding from HUVECs (Fig 5D), and this effect was diminished by SB-3CT and MMP-9 inhibitor I (Fig 5E and 5F).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3200264162017956
200,"Similarly, the supernatant from NS1-treated THP-1 cells also induced CD138 shedding from HUVECs (Fig 5D), and this effect was diminished by SB-3CT and MMP-9 inhibitor I (Fig 5E and 5F).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.3200264162017956
201,Similar results were found for the supernatant obtained from NS1-stimulated leukocytes (S6 Fig).,43,Similar results were found for the supernatant obtained from NS1-stimulated leukocytes (S6 Fig).,1.0000000000000002
202,"The NS1-blocking antibody 2E8 was used to block NS1 remaining in the supernatant, and it did not alter the endothelial permeability induced by the supernatant, showing that the effect of NS1 remaining in the supernatant is negligible (S6 Fig).",13,"To confirm that this effect was induced by NS1, anti-NS1 monoclonal antibody (mAb) was used to block the effect of NS1.",0.3325188249359037
203,"These results indicate that NS1 can induce MMP-9 secretion in leukocytes, leading to endothelial barrier dysfunction.",84,"These results indicate that NS1 can induce MMP-9 secretion in leukocytes, leading to endothelial barrier dysfunction.",1.0
204,DENV NS1-induced MMP-9 secretion from THP-1 cells causes endothelial hyperpermeability and glycocalyx degradation.,81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.43070929146441317
205,(A) PMA-activated THP-1 cells were incubated with NS1; the supernatants were collected at the indicated times and incubated with HUVECs for 24 h.,12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.20867025948811305
206,(A) PMA-activated THP-1 cells were incubated with NS1; the supernatants were collected at the indicated times and incubated with HUVECs for 24 h.,12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.20867025948811305
207,(A) PMA-activated THP-1 cells were incubated with NS1; the supernatants were collected at the indicated times and incubated with HUVECs for 24 h.,12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",0.20867025948811305
208,"(B) (C) PMA-activated THP-1 cells were incubated with NS1 for 24 h, and the resulting supernatants were collected.",41,"Similarly, NS1 induced phorbol myristate acetate (PMA)-activated THP-1 cells to secrete MMP-9 after incubation for 3 h (Fig 4D).",0.25247645903832927
209,"(B) (C) PMA-activated THP-1 cells were incubated with NS1 for 24 h, and the resulting supernatants were collected.",41,"Similarly, NS1 induced phorbol myristate acetate (PMA)-activated THP-1 cells to secrete MMP-9 after incubation for 3 h (Fig 4D).",0.25247645903832927
210,"Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatants were incubated with HUVECs, with or without the indicated concentrations of (B) SB-3CT or (C) MMP-9 inhibitor I.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.16155285532198313
211,"Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatants were incubated with HUVECs, with or without the indicated concentrations of (B) SB-3CT or (C) MMP-9 inhibitor I.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.16155285532198313
212,"Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatants were incubated with HUVECs, with or without the indicated concentrations of (B) SB-3CT or (C) MMP-9 inhibitor I.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.16155285532198313
213,"Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatants were incubated with HUVECs, with or without the indicated concentrations of (B) SB-3CT or (C) MMP-9 inhibitor I.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.16155285532198313
214,NS1-treated THP-1 cell-conditioned medium was collected at the indicated times and incubated with HUVECs for 24 h.,36,"Interestingly, the NS1-blocking antibody 2E8 only partially diminished the conditioned medium-induced HUVEC hyperpermeability but not the conditioned medium-induced HUVEC CD138 shedding (S3D and S3E Fig).",0.20768787892779586
215,The concentration of CD138 in the supernatant was determined by ELISA.,107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.21836294753637017
216,(E) (F) Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatant was mixed with or without the indicated concentrations of (E) SB-3CT or (F) MMP-9 inhibitor I and incubated with HUVECs for 24 h. The concentration of CD138 in the supernatant was determined by ELISA (n = 3).,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.2184369947974012
217,(E) (F) Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatant was mixed with or without the indicated concentrations of (E) SB-3CT or (F) MMP-9 inhibitor I and incubated with HUVECs for 24 h. The concentration of CD138 in the supernatant was determined by ELISA (n = 3).,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.2184369947974012
218,(E) (F) Fresh RPMI 1640 or NS1-treated THP-1 cell culture supernatant was mixed with or without the indicated concentrations of (E) SB-3CT or (F) MMP-9 inhibitor I and incubated with HUVECs for 24 h. The concentration of CD138 in the supernatant was determined by ELISA (n = 3).,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.2184369947974012
219,MIF is required for DENV NS1-induced MMP-9 secretion,94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.2685322137618562
220,As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9,44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.7184593746802609
221,"[19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.7553505813868274
222,"[19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.7553505813868274
223,"First, we wanted to confirm whether NS1 induces the secretion of MIF from leukocytes and THP-1 cells.",85,"First, we wanted to confirm whether NS1 induces the secretion of MIF from leukocytes and THP-1 cells.",1.0
224,Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs,70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.8340664605631346
225,Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs,70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.8340664605631346
226,"[16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.8011850962180352
227,"[16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.8011850962180352
228,The secretion of MIF from NS1-stimulated leukocytes steadily accumulated up to 2000 pg/ml (S7A Fig).,43,Similar results were found for the supernatant obtained from NS1-stimulated leukocytes (S6 Fig).,0.15882197308653645
229,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",1.0
230,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",1.0
231,"However, in THP-1 cells, NS1 only enhanced the secretion of MIF, not IL-6 or IL-8 (S7D–S7F Fig).",88,"However, in THP-1 cells, NS1 only enhanced the secretion of MIF, not IL-6 or IL-8 (S7D–S7F Fig).",1.0
232,These results suggest that MIF is the major cytokine induced by the DENV NS1 stimulation of leukocytes and monocytes.,46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,0.3545400581471027
233,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",89,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",1.0
234,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",89,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",1.0
235,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",89,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",1.0
236,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",89,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",1.0
237,"The ELISA results show that inhibiting MIF with its inhibitor p425 abolished NS1-induced MMP-9 secretion, while p425 alone did not affect MMP-9 secretion (Fig 6A).",90,"The ELISA results show that inhibiting MIF with its inhibitor p425 abolished NS1-induced MMP-9 secretion, while p425 alone did not affect MMP-9 secretion (Fig 6A).",1.0000000000000002
238,"The ELISA results show that inhibiting MIF with its inhibitor p425 abolished NS1-induced MMP-9 secretion, while p425 alone did not affect MMP-9 secretion (Fig 6A).",90,"The ELISA results show that inhibiting MIF with its inhibitor p425 abolished NS1-induced MMP-9 secretion, while p425 alone did not affect MMP-9 secretion (Fig 6A).",1.0000000000000002
239,"Next, we used shRNA to knockdown MIF expression in THP-1 cells.",89,"To clarify whether NS1-induced MMP-9 secretion is mediated by MIF, the MIF inhibitor p425 and MIF short-hairpin RNA (shRNA) were used.",0.26417006145602867
240,Western blot analysis showed that the expression of MIF was diminished by shMIF compared to the shLuc scrambled control (Fig 6B).,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.1886909309360201
241,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.9999999999999999
242,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.9999999999999999
243,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.9999999999999999
244,We also knocked down MIF expression in HUVECs and measured the permeability under NS1 stimulation as a comparison.,70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.23434706031475033
245,"Consistent with our previous study, the knockdown of MIF in HUVECs diminished NS1-induced endothelial hyperpermeability (S8A and S8B Fig).",45,"Consistent with our previous study, the knockdown of MIF in HUVECs diminished NS1-induced endothelial hyperpermeability (S8A and S8B Fig).",1.0000000000000002
246,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,1.0000000000000002
247,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,1.0000000000000002
248,NS1-induced MMP-9 secretion from THP-1 cells is regulated by MIF.,81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.30596372038296477
249,"(A) PMA-activated THP-1 cells were treated with PBS, NS1, or NS1 with p425 for 24 h, and the concentration of MMP-9 in the supernatant was determined by ELISA (n = 5).",90,"The ELISA results show that inhibiting MIF with its inhibitor p425 abolished NS1-induced MMP-9 secretion, while p425 alone did not affect MMP-9 secretion (Fig 6A).",0.24274781793228828
250,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
251,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
252,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
253,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
254,The MMP-9 levels in the supernatants of PMA-activated THP-1-shLuc and THP-1-shMIF cell cultures were detected by ELISA after incubation with or without NS1 for 24 h.,41,"Similarly, NS1 induced phorbol myristate acetate (PMA)-activated THP-1 cells to secrete MMP-9 after incubation for 3 h (Fig 4D).",0.30889118624017464
255,"PMA-activated THP-1-shLuc and THP-1-shMIF cells were incubated with PBS or NS1 for 24 h; then, the supernatant was collected and incubated with HUVEC monolayers grown in upper Transwell chambers.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.21433099582470286
256,"PMA-activated THP-1-shLuc and THP-1-shMIF cells were incubated with PBS or NS1 for 24 h; then, the supernatant was collected and incubated with HUVEC monolayers grown in upper Transwell chambers.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.21433099582470286
257,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
258,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
259,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
260,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
261,"The supernatant of THP-1-stimulated HUVEC cultures was collected, and the CD138 concentration was determined by ELISA (n = 5).",21,The results show that both the anti-MIF antibodies and OGT 2115 attenuated NS1-stimulated conditioned medium-induced HUVEC hyperpermeability and CD138 shedding (S3D and S3E Fig).,0.18638271898708275
262,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",1.0000000000000002
263,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",1.0000000000000002
264,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",1.0000000000000002
265,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",1.0000000000000002
266,The concentration of circulating NS1 in mice gradually decreased after the injection and was cleared from the plasma after 96 h (Fig 7A).,73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.194521560978941
267,"The MIF concentration increased 24 h after the injection, peaked at 72 h, and then dropped to basal levels after 96 h (Fig 7A).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",0.1857183472668272
268,"The upregulation of HPA-1 occurred later than that of MIF, as it was significantly elevated after 48 h, but it also peaked at 72 h and then dropped to basal levels after 96 h (Fig 7A).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",0.20322132111695299
269,"The secretion of MMP-9 did not increase until 72 h, and then it returned to basal levels at 96 h (Fig 7A), exhibiting an increase over a relatively short period.",82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.17024485675244755
270,MIF inhibition attenuates DENV NS1-induced glycocalyx degradation in mice.,47,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice.,0.9763359483430069
271,"Arrow, injection time point.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.08419074955521227
272,"(C-E) BALB/c mice (n = 5) were intraperitoneally injected with BSA or NS1 with or without an MIF inhibitor (ISO-1), and the peritoneal lavage fluid was collected 24 h after the injection.",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",0.22610636485064228
273,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice,47,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice.,1.0
274,"To further investigate whether NS1 causes endothelial glycocalyx degradation in mice, the skin tissues of mice after two sequential subcutaneous injections of NS1 were fixed for immunohistochemical (IHC) staining.",49,"To further investigate whether NS1 causes endothelial glycocalyx degradation in mice, the skin tissues of mice after two sequential subcutaneous injections of NS1 were fixed for immunohistochemical (IHC) staining.",1.0000000000000002
275,"After two sequential injections of NS1, endothelial cells lost their CD138 staining (Fig 7B).",49,"To further investigate whether NS1 causes endothelial glycocalyx degradation in mice, the skin tissues of mice after two sequential subcutaneous injections of NS1 were fixed for immunohistochemical (IHC) staining.",0.39471445157192975
276,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",1.0000000000000002
277,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",1.0000000000000002
278,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",1.0000000000000002
279,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",1.0000000000000002
280,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",100,"In addition, the intraperitoneal injection of NS1 significantly induced HPA-1, MMP-9, and CD138 secretion, and coinjection of ISO-1 significantly abolished the secretion of MMP-9 and CD138 but not HPA-1 found by the peritoneal lavage (Fig 7C–7E).",1.0000000000000002
281,"Furthermore, the inhibition of MIF and MMP-9 also attenuated NS1-induced vascular leakage in mice (S9 Fig).",50,"Furthermore, the inhibition of MIF and MMP-9 also attenuated NS1-induced vascular leakage in mice (S9 Fig).",1.0000000000000002
282,"Furthermore, the inhibition of MIF and MMP-9 also attenuated NS1-induced vascular leakage in mice (S9 Fig).",50,"Furthermore, the inhibition of MIF and MMP-9 also attenuated NS1-induced vascular leakage in mice (S9 Fig).",1.0000000000000002
283,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,1.0000000000000002
284,"However, only the concentrations of NS1 and MIF showed a positive correlation with CD138 in severe dengue patients.",88,"However, in THP-1 cells, NS1 only enhanced the secretion of MIF, not IL-6 or IL-8 (S7D–S7F Fig).",0.22170424316908477
285,"However, only the concentrations of NS1 and MIF showed a positive correlation with CD138 in severe dengue patients.",88,"However, in THP-1 cells, NS1 only enhanced the secretion of MIF, not IL-6 or IL-8 (S7D–S7F Fig).",0.22170424316908477
286,"Next, we showed that the DENV NS1 stimulation of endothelial cells and leukocytes could induce HPA-1 and MMP-9 secretion, respectively, causing endothelial glycocalyx degradation and hyperpermeability.",103,"Next, we showed that the DENV NS1 stimulation of endothelial cells and leukocytes could induce HPA-1 and MMP-9 secretion, respectively, causing endothelial glycocalyx degradation and hyperpermeability.",1.0000000000000002
287,"Next, we showed that the DENV NS1 stimulation of endothelial cells and leukocytes could induce HPA-1 and MMP-9 secretion, respectively, causing endothelial glycocalyx degradation and hyperpermeability.",103,"Next, we showed that the DENV NS1 stimulation of endothelial cells and leukocytes could induce HPA-1 and MMP-9 secretion, respectively, causing endothelial glycocalyx degradation and hyperpermeability.",1.0000000000000002
288,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.9999999999999999
289,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.9999999999999999
290,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.9999999999999999
291,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",56,"Most importantly, both in vitro and in vivo data showed that dengue NS1-induced HPA-1 and MMP-9 secretion was MIF dependent.",0.9999999999999999
292,"Therefore, these results suggest that MIF is a central modulator of both direct and indirect dengue NS1-induced endothelial glycocalyx degradation (Fig 8).",57,"Therefore, these results suggest that MIF is a central modulator of both direct and indirect dengue NS1-induced endothelial glycocalyx degradation (Fig 8).",1.0
293,The proposed mechanisms of DENV NS1-induced endothelial glycocalyx degradation.,47,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice.,0.27760571753081775
294,"Circulating DENV NS1 may bind to endothelial cells via TLR4 or other molecules to stimulate the secretion of MIF, which in turn elevates the protein level of active HPA-1, causing it to digest glycocalyx on the intravascular luminal surface of endothelial cells.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.3965257036886145
295,"Circulating DENV NS1 may bind to endothelial cells via TLR4 or other molecules to stimulate the secretion of MIF, which in turn elevates the protein level of active HPA-1, causing it to digest glycocalyx on the intravascular luminal surface of endothelial cells.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.3965257036886145
296,"Circulating DENV NS1 may bind to endothelial cells via TLR4 or other molecules to stimulate the secretion of MIF, which in turn elevates the protein level of active HPA-1, causing it to digest glycocalyx on the intravascular luminal surface of endothelial cells.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.3965257036886145
297,"Circulating DENV NS1 may bind to endothelial cells via TLR4 or other molecules to stimulate the secretion of MIF, which in turn elevates the protein level of active HPA-1, causing it to digest glycocalyx on the intravascular luminal surface of endothelial cells.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.3965257036886145
298,"On the other hand, NS1 can also bind to TLR4 on leukocytes to secrete MMP-9, causing glycocalyx degradation.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.2782872245919288
299,"On the other hand, NS1 can also bind to TLR4 on leukocytes to secrete MMP-9, causing glycocalyx degradation.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.2782872245919288
300,"Even though the effector molecules causing glycocalyx degradation (HPA-1 and MMP-9) are different, MIF is part of both HPA-1 secretion by endothelial cells and MMP-9 secretion by leukocytes.",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.3294627530442258
301,"Even though the effector molecules causing glycocalyx degradation (HPA-1 and MMP-9) are different, MIF is part of both HPA-1 secretion by endothelial cells and MMP-9 secretion by leukocytes.",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.3294627530442258
302,"Previously, Puerta-Guardo et al. showed that HPA-1 is involved in NS1-induced glycocalyx degradation and hyperpermeability [18].",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",0.24824129064379435
303,It is known that DENV infection induces dendritic cells to secrete MMP-9,58,It is known that DENV infection induces dendritic cells to secrete MMP-9 [31].,0.9095153234757324
304,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
305,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
306,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
307,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
308,"In this study, we further demonstrated that the NS1 stimulation of leukocytes but not endothelial cells nor PBMCs could induce MMP-9 secretion.",105,"In this study, we further demonstrated that the NS1 stimulation of leukocytes but not endothelial cells nor PBMCs could induce MMP-9 secretion.",1.0000000000000002
309,"It is known that DENV NS1 can induce neutrophil extracellular traps, which results in the release of tertiary granules containing MMP-9",58,It is known that DENV infection induces dendritic cells to secrete MMP-9 [31].,0.26239753843854385
310,A previous study has also shown that MIF can mediate the secretion of MMP-9 from neutrophils [39].,106,A previous study has also shown that MIF can mediate the secretion of MMP-9 from neutrophils [39].,1.0000000000000002
311,"Since neutrophils are a major population of leukocytes, taken together, these results suggest that NS1-stimulated neutrophils may represent the main contributors to MMP-9 secretion in the blood.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.28181065863631505
312,"Therefore, even though neutrophils are not the primary target of DENV infection [40, 41], the secretion of MMP-9 from neutrophils induced by NS1 may also contribute to vascular leakage during DENV infection.",106,A previous study has also shown that MIF can mediate the secretion of MMP-9 from neutrophils [39].,0.24339327803885158
313,"Interestingly, although it has been shown in previous studies that the concentrations of MMPs are increased in dengue patients [13, 32]",106,A previous study has also shown that MIF can mediate the secretion of MMP-9 from neutrophils [39].,0.20537783084224215
314,and MMP-9 upregulation is positively correlated with the disease severity and vascular leakage of dengue,82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.2816847787702217
315,"[31, 32, 42, 43], we observed a significant increase in the serum level of MMP-9 only in dengue patients with warning signs, not in severe dengue patients.",82,"Because a previous study has indicated that an increase in circulating MMP-9 levels is associated with dengue disease severity [32], we first examined whether NS1 induces MMP-9 secretion.",0.21171626888132003
316,"From the in vivo mouse study, we noticed that the secretion of MMP-9 occurred within a smaller time window than that of HPA-1 in mice after NS1 challenge.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",0.2935790582520636
317,"From the in vivo mouse study, we noticed that the secretion of MMP-9 occurred within a smaller time window than that of HPA-1 in mice after NS1 challenge.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",0.2935790582520636
318,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",59,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",0.9999999999999999
319,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",59,"From the results of the MMP antibody array, we also found that MMP-8 and tissue inhibitor of metalloproteinases 1 (TIMP-1) were upregulated by NS1-stimulated leukocytes.",0.9999999999999999
320,"TIMP-1, which is a potent inhibitor of MMPs, can form a complex with pro-MMP-9 at a 1:1 stoichiometric relationship to inhibit its activation [44, 45].",62,"TIMP-1, which is a potent inhibitor of MMPs, can form a complex with pro-MMP-9 at a 1:1 stoichiometric relationship to inhibit its activation [44, 45].",1.0000000000000007
321,"However, neutrophil elastase can inactivate TIMP-1 in the complex to free pro-MMP-9, such that it can be activated by MMP-3 [46].",63,"However, neutrophil elastase can inactivate TIMP-1 in the complex to free pro-MMP-9, such that it can be activated by MMP-3 [46].",1.0
322,"However, neutrophil elastase can inactivate TIMP-1 in the complex to free pro-MMP-9, such that it can be activated by MMP-3 [46].",63,"However, neutrophil elastase can inactivate TIMP-1 in the complex to free pro-MMP-9, such that it can be activated by MMP-3 [46].",1.0
323,"In addition, myeloperoxidase, which is most abundantly expressed by neutrophils, can also inactivate TIMP-1 via generating hypochlorous acid",64,"In addition, myeloperoxidase, which is most abundantly expressed by neutrophils, can also inactivate TIMP-1 via generating hypochlorous acid [47].",0.9476626290465056
324,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
325,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
326,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
327,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
328,These possible mechanisms may explain why MMP-9 activity was not abrogated in the presence of TIMP-1 in NS1-stimulated leukocytes.,55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.22889700352660275
329,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage",65,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage [16].",0.9611087952557701
330,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage",65,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage [16].",0.9611087952557701
331,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage",65,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage [16].",0.9611087952557701
332,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage",65,"A previous study has shown that NS1 can induce PBMCs to secrete IL-6 and IL-8 via Toll-like receptor 4 (TLR4), leading to vascular leakage [16].",0.9611087952557701
333,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
334,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
335,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
336,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
337,"However, in this study, we found that the secretion of IL-6 and IL-8 dropped rapidly after 3 h of NS1-stimulation in leukocytes (S7B and S7C Fig).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",0.5910600275071066
338,"However, in this study, we found that the secretion of IL-6 and IL-8 dropped rapidly after 3 h of NS1-stimulation in leukocytes (S7B and S7C Fig).",86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",0.5910600275071066
339,"In contrast, MIF steadily accumulated in the supernatant of leukocyte cultures after NS1 treatment, and the concentration of MIF was higher than that of IL-6 and IL-8 (S7 Fig).",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.33733341930760047
340,"As NS1 needs at least 24 h to induce endothelial glycocalyx degradation (Fig 3A), we speculated that IL-6 and IL-8 are not very involved in NS1-induced endothelial glycocalyx degradation.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.2994906981136375
341,"As NS1 needs at least 24 h to induce endothelial glycocalyx degradation (Fig 3A), we speculated that IL-6 and IL-8 are not very involved in NS1-induced endothelial glycocalyx degradation.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.2994906981136375
342,"As NS1 needs at least 24 h to induce endothelial glycocalyx degradation (Fig 3A), we speculated that IL-6 and IL-8 are not very involved in NS1-induced endothelial glycocalyx degradation.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.2994906981136375
343,"This speculation is consistent with a recent study performed by Glasner et al., which found that DENV NS1 does not induce HMEC-1 human endothelial cells to secrete TNF-α, IL-6 or IL-8 and that blocking these cytokines does not affect DENV NS1-induced endothelial hyperpermeability [48].",67,"In our previous study and in this study, we demonstrated that NS1 induced HMEC-1 cells or HUMECs to secrete MIF, causing endothelial hyperpermeability [19].",0.2393810716676916
344,"This speculation is consistent with a recent study performed by Glasner et al., which found that DENV NS1 does not induce HMEC-1 human endothelial cells to secrete TNF-α, IL-6 or IL-8 and that blocking these cytokines does not affect DENV NS1-induced endothelial hyperpermeability [48].",67,"In our previous study and in this study, we demonstrated that NS1 induced HMEC-1 cells or HUMECs to secrete MIF, causing endothelial hyperpermeability [19].",0.2393810716676916
345,"This speculation is consistent with a recent study performed by Glasner et al., which found that DENV NS1 does not induce HMEC-1 human endothelial cells to secrete TNF-α, IL-6 or IL-8 and that blocking these cytokines does not affect DENV NS1-induced endothelial hyperpermeability [48].",67,"In our previous study and in this study, we demonstrated that NS1 induced HMEC-1 cells or HUMECs to secrete MIF, causing endothelial hyperpermeability [19].",0.2393810716676916
346,"On the other hand, the same study found that inhibition of HPA-1 prevents DENV NS1-induced endothelial hyperpermeability",47,MIF inhibition attenuates DENV NS1-induced endothelial glycocalyx degradation in mice.,0.22340603785021765
347,"In our previous study and in this study, we demonstrated that NS1 induced HMEC-1 cells or HUMECs to secrete MIF, causing endothelial hyperpermeability [19].",67,"In our previous study and in this study, we demonstrated that NS1 induced HMEC-1 cells or HUMECs to secrete MIF, causing endothelial hyperpermeability [19].",1.0000000000000002
348,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.9999999999999999
349,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.9999999999999999
350,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.9999999999999999
351,"Due to MIF regulating the secretion of both MMP-9 and HPA-1 and because CD138 shedding was also directly affected by MIF signaling, MIF may be an upstream regulator of DENV NS1-induced glycocalyx degradation.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.2959011770196447
352,"Due to MIF regulating the secretion of both MMP-9 and HPA-1 and because CD138 shedding was also directly affected by MIF signaling, MIF may be an upstream regulator of DENV NS1-induced glycocalyx degradation.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.2959011770196447
353,"Due to MIF regulating the secretion of both MMP-9 and HPA-1 and because CD138 shedding was also directly affected by MIF signaling, MIF may be an upstream regulator of DENV NS1-induced glycocalyx degradation.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.2959011770196447
354,"Due to MIF regulating the secretion of both MMP-9 and HPA-1 and because CD138 shedding was also directly affected by MIF signaling, MIF may be an upstream regulator of DENV NS1-induced glycocalyx degradation.",44,"As MIF is a crucial mediator of NS1-induced vascular leakage and an upstream regulator of MMP-9 [19, 26, 34, 35], we tested whether NS1-induced MMP-9 secretion in leukocytes is also MIF dependent.",0.2959011770196447
355,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",108,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",1.0000000000000002
356,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",108,"However, the mechanism of how MIF causes HPA-1 and MMP-9 secretion is still unclear.",1.0000000000000002
357,A previous study has shown that MIF induces MMP-9 expression in macrophages via the MAPK pathway,72,A previous study has shown that MIF induces MMP-9 expression in macrophages via the MAPK pathway [35].,0.9310495371134899
358,A previous study has shown that MIF induces MMP-9 expression in macrophages via the MAPK pathway,72,A previous study has shown that MIF induces MMP-9 expression in macrophages via the MAPK pathway [35].,0.9310495371134899
359,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
360,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
361,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
362,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
363,MIF is also known to activate NF-κB signaling through binding to CD74 [49].,110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.24380307218965946
364,"Additionally, HPA-1 mRNA expression is elevated in an NF-κB-dependent manner during hypoxia [50].",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",0.21722400265505698
365,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",1.0000000000000002
366,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",110,"Therefore, it is possible that MIF contributes to the secretion of HPA-1 and MMP-9 via the MAPK/NF-κB pathway.",1.0000000000000002
367,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",1.0000000000000004
368,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",1.0000000000000004
369,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",1.0000000000000004
370,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",1.0000000000000004
371,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",112,"However, from our in vivo study, we also noticed that NS1-induced MMP-9 secretion and CD138 shedding were significantly attenuated by MIF inhibition, whereas the attenuation of HPA-1 secretion was not as significant.",1.0000000000000004
372,Serum samples from severe dengue patients also showed no linear relationship between the concentrations of MIF and HPA-1 (S10 Fig).,86,"NS1 could also enhance the secretion of IL-6 and IL-8 from leukocytes, but the concentrations dropped rapidly after 3 h (S7 B and S7C Fig).",0.14617540529941747
373,"These results may suggest that in addition to MIF, other factors may participate in the regulation of HPA-1 secretion in vivo.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.34219986745365555
374,"Taken together, our results suggest that NS1 may contribute to vascular leakage through different mechanisms during DENV infection.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.1893151939669373
375,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",1.0
376,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",1.0
377,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",1.0
378,"Consequently, NS1 may represent an important viral factor that causes vascular leakage and glycocalyx degradation during DENV infection.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.2801512979382167
379,"Consequently, NS1 may represent an important viral factor that causes vascular leakage and glycocalyx degradation during DENV infection.",55,These results suggest that MMP-9 induced by NS1-stimulated leukocytes may play an important role in endothelial glycocalyx degradation.,0.2801512979382167
380,"Indeed, antibodies against NS1 have been shown to be protective against DENV infection in mice [17, 51, 52].",10,"Furthermore, DENV infection-induced disease was found to be less severe in MIF knockout (Mif  ) mice than in normal mice [29].",0.1872080600381678
381,"Furthermore, MIF may represent the primary host factor that mediates NS1-induced glycocalyx degradation.",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0.22676788599898437
382,Studies focusing on the development of neutralizing antibodies or small molecules against MIF may facilitate the development of drugs to prevent or treat severe dengue [53].,113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.1319198456196419
383,Studies focusing on the development of neutralizing antibodies or small molecules against MIF may facilitate the development of drugs to prevent or treat severe dengue [53].,113,"DENV NS1 may bind to the TLR4 of leukocytes, inducing the secretion of cytokines and MMPs, or it may directly bind to endothelial cells, inducing the secretion of HPA-1, both of which can cause glycocalyx degradation and subsequent vascular leakage.",0.1319198456196419
384,"From analyzing clinical samples, we correlated glycocalyx degradation to MIF secretion.",97,"To further confirm that NS1 can induce MIF, HPA-1, MMP-9 and CD138 secretion in vivo, we injected 50 μg of NS1 into the tail veins of mice, and blood samples were collected every 24 h.",0.17196059357695506
385,"By applying the results from other studies, we hypothesized that HPA-1 or MMP-9 was involved in MIF-mediated glycocalyx degradation in dengue.",80,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",0.25484405531467336
386,"By applying the results from other studies, we hypothesized that HPA-1 or MMP-9 was involved in MIF-mediated glycocalyx degradation in dengue.",80,"These results indicate that NS1 can induce the MIF-mediated secretion of active HPA-1, leading to endothelial glycocalyx degradation.",0.25484405531467336
387,"This hypothesis was examined via in vitro experiments, which were carried out by recombinant NS1 stimulation, as it was indicated as an important effector in severe dengue.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.19537550389183786
388,"Since the interaction between different cell types is critical under physiological conditions, we assessed the DENV NS1-induced effects on both endothelial cells and leukocytes.",46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,0.20011113005232833
389,"Since the interaction between different cell types is critical under physiological conditions, we assessed the DENV NS1-induced effects on both endothelial cells and leukocytes.",46,These results suggest that MIF acts on both endothelial cells and leukocytes to mediate NS1-induced endothelial hyperpermeability.,0.20011113005232833
390,"To further elucidate the involvement of MMPs in this mechanism, MMP antibody array and gelatin zymography assays were performed.",42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.2843213889768293
391,"To further elucidate the involvement of MMPs in this mechanism, MMP antibody array and gelatin zymography assays were performed.",42,"To obtain the secretion profile of MMPs, we used an MMP antibody array to analyze which MMPs were increased by NS1 in PMA-activated THP-1 cells and leukocytes.",0.2843213889768293
392,"Subsequently, recombinant NS1 was injected into mice systemically or locally to confirm the involvement of MIF, HPA-1 and MMP-9 in NS1-induced endothelial glycocalyx degradation and hyperpermeability in vivo.",97,"To further confirm that NS1 can induce MIF, HPA-1, MMP-9 and CD138 secretion in vivo, we injected 50 μg of NS1 into the tail veins of mice, and blood samples were collected every 24 h.",0.35967361429642847
393,"Subsequently, recombinant NS1 was injected into mice systemically or locally to confirm the involvement of MIF, HPA-1 and MMP-9 in NS1-induced endothelial glycocalyx degradation and hyperpermeability in vivo.",97,"To further confirm that NS1 can induce MIF, HPA-1, MMP-9 and CD138 secretion in vivo, we injected 50 μg of NS1 into the tail veins of mice, and blood samples were collected every 24 h.",0.35967361429642847
394,"Subsequently, recombinant NS1 was injected into mice systemically or locally to confirm the involvement of MIF, HPA-1 and MMP-9 in NS1-induced endothelial glycocalyx degradation and hyperpermeability in vivo.",97,"To further confirm that NS1 can induce MIF, HPA-1, MMP-9 and CD138 secretion in vivo, we injected 50 μg of NS1 into the tail veins of mice, and blood samples were collected every 24 h.",0.35967361429642847
395,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
396,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
397,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
398,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
399,"These proteins were tested for endotoxin concentration by the Limulus amebocyte lysate (LAL) assay using the LAL Chromogenic Endotoxin Kit (Thermo Fisher Scientific, Waltham, MA, USA) and were shown to be endotoxin-free (<0.1 EU/ml).",63,"However, neutrophil elastase can inactivate TIMP-1 in the complex to free pro-MMP-9, such that it can be activated by MMP-3 [46].",0.08640250149576373
400,"These proteins were cloned, expressed and purified from E. coli using Sepharose (GE Healthcare, Chicago, IL, USA), chelated with 500 mM cobalt chloride, and then slowly dialyzed against PBS.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.11100510751092454
401,"These proteins were cloned, expressed and purified from E. coli using Sepharose (GE Healthcare, Chicago, IL, USA), chelated with 500 mM cobalt chloride, and then slowly dialyzed against PBS.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.11100510751092454
402,"These proteins were cloned, expressed and purified from E. coli using Sepharose (GE Healthcare, Chicago, IL, USA), chelated with 500 mM cobalt chloride, and then slowly dialyzed against PBS.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.11100510751092454
403,"These proteins were cloned, expressed and purified from E. coli using Sepharose (GE Healthcare, Chicago, IL, USA), chelated with 500 mM cobalt chloride, and then slowly dialyzed against PBS.",70,"Since a previous study has shown that NS1 increases the expression of IL-6 and IL-8 in PBMCs [16], we also measured the concentrations of IL-6 and IL-8 after NS1 stimulation.",0.11100510751092454
404,"Heparan sulfate and thrombin with protease activity were purchased from Sigma-Aldrich (St. Louis, MO, USA) and were used in several studies",7,"Activated HPA-1 enhances shedding of the transmembrane heparan sulfate proteoglycan syndecan-1 (CD138) and elevates the level of CD138 in the bloodstream [7, 9, 10].",0.14242908336189558
405,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
406,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
407,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
408,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
409,"To inhibit MIF activity, HUVECs were cotreated for 24 h with NS1 and either 100 μM p425 (6,6ʹ-[(3,3-dimethoxy[1,1ʹ-biphenyl]-4,4ʹ-diyl)bis(azo)]bis[4-amino-5-hydroxy-1,3-napthalenedisulphonic acid] tetrasodium salt; Calbiochem, La Jolla, CA, USA) or 50 μM ISO-1 ((S,R)-3-(4-hydroxyphenyl)-4,5-dihydro-5-isoxazole acetic acid; Calbiochem).",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.07150509563828683
410,"To inhibit HPA-1, OGT 2115 (Tocris Bioscience, Bristol, UK) was used at the indicated concentration.",17,"To confirm that HPA-1 is involved in NS1-induced endothelial hyperpermeability and CD138 shedding, recombinant HPA-1 protein and the HPA-1 inhibitor OGT 2115 were used.",0.21627287011511004
411,"To inhibit MMP-9, SB-3CT (Abcam, Cambridge, UK) and MMP-9 inhibitor I (Santa Cruz, Dallas, TX, USA) were used at the indicated concentrations.",62,"TIMP-1, which is a potent inhibitor of MMPs, can form a complex with pro-MMP-9 at a 1:1 stoichiometric relationship to inhibit its activation [44, 45].",0.13652353827818808
412,"To inhibit MMP-9, SB-3CT (Abcam, Cambridge, UK) and MMP-9 inhibitor I (Santa Cruz, Dallas, TX, USA) were used at the indicated concentrations.",62,"TIMP-1, which is a potent inhibitor of MMPs, can form a complex with pro-MMP-9 at a 1:1 stoichiometric relationship to inhibit its activation [44, 45].",0.13652353827818808
413,"THP-1 cells were infected with lentivirus and underwent selection in culture medium containing puromycin (1 μg/ml, Sigma-Aldrich).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.12495947542308772
414,"THP-1 cells were infected with lentivirus and underwent selection in culture medium containing puromycin (1 μg/ml, Sigma-Aldrich).",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.12495947542308772
415,"NS1 stimulation of THP-1 cells, human leukocytes and PBMCs",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.39519354810515783
416,"NS1 stimulation of THP-1 cells, human leukocytes and PBMCs",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.39519354810515783
417,"NS1 stimulation of THP-1 cells, human leukocytes and PBMCs",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.39519354810515783
418,THP-1 cells were suspended in medium containing 5 ng/ml PMA (Sigma-Aldrich).,81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.13865846616941335
419,"NS1 (20 μg/ml) was used to stimulate THP-1 cells, human leukocytes and PBMCs, and the resultant culture supernatants were collected at the indicated time points.",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.19658562698804843
420,"NS1 (20 μg/ml) was used to stimulate THP-1 cells, human leukocytes and PBMCs, and the resultant culture supernatants were collected at the indicated time points.",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.19658562698804843
421,"NS1 (20 μg/ml) was used to stimulate THP-1 cells, human leukocytes and PBMCs, and the resultant culture supernatants were collected at the indicated time points.",81,DENV NS1 induces MMP-9 secretion in THP-1 cells and leukocytes.,0.19658562698804843
422,"The upper chambers were reconstituted with 20 μg/ml NS1, culture supernatant from NS1-activated THP-1 cells, or the inhibitor-containing medium.",93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.2537202762451477
423,"Next, 20 μl of medium in the lower chamber was collected 5 min after the addition of streptavidin-HRP and was assayed for HRP activity by the addition of 100 μl of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (R&D Systems).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.20179101100156846
424,"To measure the integrity of the endothelial glycocalyx and the deposition of CD138, the expression of sialic acid was stained with wheat germ agglutinin (WGA) lectin conjugated to FITC (WGA-FITC, Genetex)",69,"As shown in Fig 3G, NS1-induced HPA-1 expression, CD138 deposition and sialic acid degradation could also be rescued by MIF inhibition.",0.1937608245363951
425,"the distribution of HPA-1 and CD138 was detected by anti-mouse-CD138 mAb (BD, Franklin Lakes, NJ, USA)",74,"NS1 stimulation also increased the active HPA-1 level in endothelial cell lysates, which was abolished by mAb 2E8 but not control mouse IgG (S2A Fig).",0.18314298978103297
426,the distribution of HPA-1 and CD138 was detected by... rabbit anti-HPA-1 polyclonal antibody (GeneTex),13,"To confirm that this effect was induced by NS1, anti-NS1 monoclonal antibody (mAb) was used to block the effect of NS1.",0.18595195870022707
427,"Primary antibodies were incubated with the fixed monolayer overnight at 4°C, followed by incubation with Alexa 488-conjugated goat anti-mouse IgG secondary antibody",74,"NS1 stimulation also increased the active HPA-1 level in endothelial cell lysates, which was abolished by mAb 2E8 but not control mouse IgG (S2A Fig).",0.1480163462896113
428,"Primary antibodies were incubated with the fixed monolayer overnight at 4°C, followed by incubation with Alexa 594-conjugated goat anti-rabbit IgG secondary antibody",74,"NS1 stimulation also increased the active HPA-1 level in endothelial cell lysates, which was abolished by mAb 2E8 but not control mouse IgG (S2A Fig).",0.08559258176057374
429,"Primary antibodies were incubated with the fixed monolayer overnight at 4°C, followed by incubation with Hoechst 33342",49,"To further investigate whether NS1 causes endothelial glycocalyx degradation in mice, the skin tissues of mice after two sequential subcutaneous injections of NS1 were fixed for immunohistochemical (IHC) staining.",0.08593307036342283
430,"After washing with commercial wash buffer, the membranes were incubated with biotin-conjugated anti-MMP antibodies, followed by HRP-conjugated streptavidin.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.09709794636665733
431,"After washing with commercial wash buffer, the membranes were incubated with biotin-conjugated anti-MMP antibodies, followed by HRP-conjugated streptavidin.",73,"Moreover, HPA-1, MMP-9, and CD138 secretion after NS1 stimulation was blocked by MIF inhibitors or antibodies both in vitro and in mice.",0.09709794636665733
432,"Bound HRP-conjugated antibodies were detected using the Luminata Crescendo Western HRP substrate (Merck Millipore, Darmstadt, Germany).",19,"To clarify which protein mediates NS1-induced endothelial hyperpermeability and CD138 shedding, MIF-blocking antibodies, the HPA-1 inhibitor OGT 2115 and NS1-blocking antibodies were used.",0.06440442276538998
433,MMP activity in the culture supernatant was assayed by gelatin zymography using 7.5% acrylamide gel containing gelatin,93,"Furthermore, the knockdown of MIF decreased NS1-induced MMP-9 secretion from THP-1 cells (Fig 6B), and the culture supernatant from shMIF THP-1 cells failed to increase endothelial permeability or CD138 shedding (Fig 6C and 6D).",0.0883670575549462
434,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
435,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",0,"Nonstructural protein 1 (NS1) of dengue virus (DENV) can stimulate endothelial cells to secrete endothelial hyperpermeability factor, macrophage migration inhibitory factor (MIF), and the glycocalyx degradation factor heparanase 1 (HPA-1).",1.0000000000000002
436,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",11,"According to a previous study, NS1 can induce endothelial cells to secrete HPA-1 to disrupt the endothelial glycocalyx, and this disruption is characterized by CD138 shedding [18].",1.0
437,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",12,"To further investigate the underlying mechanism of NS1-induced HPA-1 secretion, human umbilical vein endothelial cells (HUVECs) were stimulated with NS1 for various durations.",1.0
438,The gels were subsequently renatured and developed before being stained with Coomassie blue to reveal the positions of active gelatinases (clear bands) against the undigested gelatin substrate in the gel.,79,The results show that MIF increased CD138 shedding and the active HPA-1 level in HUVECs (S4A and S4B Fig).,0.10335028543814545
439,"DENV NS1-induced MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.8129057452477851
440,"DENV NS1-induced MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.8129057452477851
441,"DENV NS1-induced MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.8129057452477851
442,"DENV NS1-induced MIF, HPA-1, MMP-9 and CD138 secretion in mice",94,"DENV NS1 induces MIF, HPA-1, MMP-9 and CD138 secretion in mice.",0.8129057452477851
443,"To further confirm that NS1 induced CD138 shedding in endothelial cells in mice, 50 μg of recombinant NS1, E or prM protein or 50 μl of PBS was subcutaneously injected into 8- to 12-week-old BALB/c mice, followed by a second injection of an equal amount of recombinant proteins or PBS 24 h after the first injection at the same site.",97,"To further confirm that NS1 can induce MIF, HPA-1, MMP-9 and CD138 secretion in vivo, we injected 50 μg of NS1 into the tail veins of mice, and blood samples were collected every 24 h.",0.32435837507373966
444,"NS1 ELISA was carried out using paired anti-NS1 antibodies prepared in our laboratory and was quantified by the addition of 100 μl of 3,3',5,5'-tetramethylbenzidine (TMB) substrate (R&D Systems).",107,"In addition, we further demonstrated that both the secretion of HPA-1 and the shedding of CD138 induced by NS1-stimulation of endothelial cells are mediated by MIF.",0.14988603353336852
